Burden of Human Papillomavirus among Haitian Immigrants in Miami, Florida: Community-Based Participatory Research in Action

Erin Kobetz, Jonathan K Kish, Nicole G Campos, Tulay Koru-Sengul, Ian Bishop, Hannah Lipshultz, Betsy Barton, Lindley Barbee, Erin Kobetz, Jonathan K Kish, Nicole G Campos, Tulay Koru-Sengul, Ian Bishop, Hannah Lipshultz, Betsy Barton, Lindley Barbee

Abstract

Background. Haitian immigrant women residing in Little Haiti, a large ethnic enclave in Miami-Dade County, experience the highest cervical cancer incidence rates in South Florida. While this disparity primarily reflects lack of access to screening with cervical cytology, the burden of human papillomavirus (HPV) which causes virtually all cases of cervical cancer worldwide, varies by population and may contribute to excess rate of disease. Our study examined the prevalence of oncogenic and nononcogenic HPV types and risk factors for HPV infection in Little Haiti. Methods. As part of an ongoing community-based participatory research initiative, community health workers recruited study participants between 2007 and 2008, instructed women on self-collecting cervicovaginal specimens, and collected sociodemographic and healthcare access data. Results. Of the 242 women who contributed adequate specimens, the overall prevalence of HPV was 20.7%, with oncogenic HPV infections (13.2% of women) outnumbering nononcogenic infections (7.4%). Age-specific prevalence of oncogenic HPV was highest in women 18-30 years (38.9%) although the prevalence of oncogenic HPV does not appear to be elevated relative to the general U.S. population. The high prevalence of oncogenic types in women over 60 years may indicate a substantial number of persistent infections at high risk of progression to precancer.

Figures

Figure 1
Figure 1
Self-sampling device brochure.
Figure 2
Figure 2
Age-specific prevalence of cervical human papillomavirus (HPV) DNA by LR, HR, and HR Types 16 and 18. Vertical bars indicated 95% confidence intervals of overall HPV prevalence. (Black) HPV 16 and/or 18 (including co-infection), (grey) all other HR-HPV, (white) LR-HPV only.

References

    1. FCDS. Florida Cancer Data System, 2007.
    1. Barbee L, Kobetz E, Menard J, et al. Assessing the acceptability of self-sampling for HPV among haitian immigrant women: CBPR in action. Cancer Causes & Control. 2009;21(3):421–431.
    1. Kobetz E, Menard J, Diem J, et al. Community-based participatory research in Little Haiti: challenges and lessons learned. Progress in Community Health Partnerships: Research, Education, and Action. 2009;3(2):133–137.
    1. Gustafsson L, Pontén J, Zack M, Adami HO. International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes and Control. 1997;8(5):755–763.
    1. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. Ca-A Cancer Journal for Clinicians. 2002;52(6):342–362.
    1. Saint-Jean G, Crandall LA. Sources and barriers to health care coverage for Haitian immigrants in Miami-Dade county, Florida. Journal of Health Care for the Poor and Underserved. 2005;16(1):29–41.
    1. Echeverria SE, Carrasquillo O. The roles of citizenship status, acculturation, and health insurance in breast and cervical cancer screening among immigrant women. Medical Care. 2006;44(8):788–792.
    1. Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. Journal of Clinical Pathology. 2002;55(4):244–265.
    1. Menard J, Kobetz E, Maldonado JC, Barton B, Blanco J, Diem J. Barriers to cervical cancer screening among haitian immigrant women in Little Haiti, Miami. Journal of Cancer Education. 2010;25(4):602–608.
    1. Israel B, Schulz A, Parker E, Becker A, Allen A, Guzman R. Critical Issues in Developing and Following Community Based Research Principles. San Francisco, Calif, USA: Jossey-Bass; 2003.
    1. Minkler M, Wallerstein N. Community-Based Participatory Research for Health. San Francisco, Calif, USA: Jossey-Bass; 2003.
    1. Edgren K, Parker E, Israel B, et al. Community involvement in the conduct of a health education intervention and research project: community action against asthma. Health Promotion Practice. 2005;6(3):263–269.
    1. Knesel BW, Dry JC, Wald-Scott C, Aftab A. Preliminary evaluation of a cervical self-sampling device with liquid-based cytology and multiparameter molecular testing. Journal of Reproductive Medicine. 2005;50(4):256–260.
    1. Castle PE, Aftab A, Saint-Jean G, Mendez L. Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device. Journal of Clinical Microbiology. 2006;44(6):2158–2159.
    1. Awen C, Hathway S, Eddy W, Voskuil R, Janes C. Efficacy of Thinprep® preparation of cervical smears: a 1,000-case, investigator-sponsored study. Diagnostic Cytopathology. 1994;11(1):33–36.
    1. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens—part B: biological agents. The Lancet Oncology. 2009;10(4):321–322.
    1. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine. 2003;348(6):518–527.
    1. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. Journal of the American Medical Association. 2007;297(8):813–819.
    1. Chaturvedi AK, Dumestre J, Gaffga AM, et al. Prevalence of human papillomavirus genotypes in women from three clinical settings. Journal of Medical Virology. 2005;75(1):105–113.
    1. Khanna N, Mishra SI, Tian G, et al. Human papillomavirus detection in self-collected vaginal specimens and matched clinician-collected cervical specimens. International Journal of Gynecological Cancer. 2007;17(3):615–622.
    1. Datta SD, Koutsky LA, Ratelle S, et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003–2005. Annals of Internal Medicine. 2008;148(7):493–500.
    1. Goodman MT, Shvetsov YB, McDuffie K, et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Research. 2008;68(21):8813–8824.
    1. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) Human Papillomavirus and Related Cancers in the United States of America. Summary Report 2010. , 2011.
    1. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. The Lancet. 2005;366(9490):991–998.
    1. Castle PE, Rodriguez AC, Porras C, et al. A comparison of cervical and vaginal human papillomavirus. Sexually Transmitted Diseases. 2007;34(11):849–855.
    1. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) Human Papillomavirus and Related Cancers in Haiti. Summary Report 2010. , 2011.
    1. Ragin CCR, Wheeler VW, Wilson JB, et al. Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago. Biomarkers. 2007;12(5):510–522.
    1. Watt A, Garwood D, Jackson M, et al. High-risk and multiple human papillomavirus (HPV) infections in cancer-free Jamaican women. Infectious Agents and Cancer. 2009;4(supplement 1):S1–S11.
    1. Andall-Brereton GM, Hosein F, Salas RA, et al. Human papillomavirus genotypes and their prevalence in a cohort of women in Trinidad. Revista Panamericana de Salud Pública. 2011;29(4):220–226.
    1. Wang SS, Wheeler CM, Hildesheim A, et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. Journal of Infectious Diseases. 2001;184(10):1310–1314.
    1. Strickler HD, Palefsky JM, Shah KV, et al. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. Journal of the National Cancer Institute. 2003;95(14):1062–1071.
    1. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) Human Papillomavirus and Related Cancers in the Americas. Summary Report 2010. , 2011.
    1. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. International Journal of Cancer. 2006;119(11):2677–2684.
    1. Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. Journal of Infectious Diseases. 2005;191(11):1796–1807.
    1. Rodríguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. Journal of the National Cancer Institute. 2008;100(7):513–517.
    1. National Cancer Institute Fact Sheet: pap test, , 2011.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する